In April 2025, InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced its consolidated financial results for the first quarter ended March 31, 2025. The company reported quarterly GAAP revenues of $77.9 million, marking a 3% decrease compared to $80.3 million in the first quarter of 2024. Revenues from consumables and service amounted to $20.2 million, showing a 10% decline year-over-year.
InMode’s GAAP operating income stood at $15.6 million, while non-GAAP operating income was $18.1 million. The company maintained a strong cash position of $512.9 million as of March 31, 2025. Additionally, InMode completed the repurchase of 6.95 million ordinary shares in April 2025, returning $127 million of capital to shareholders.
CEO Moshe Mizrahy noted that the challenging macroeconomic environment and weakened consumer demand impacted Q1 2025 performance. CFO Yair Malca highlighted the company’s commitment to disciplined capital allocation, including potential dividends and strategic M&A opportunities.
For the full year 2025, InMode expects revenues between $395 to $405 million, with non-GAAP gross margins ranging from 78% to 80%.
— new from PR Newswire